Skip to content

Jesper Haaning

Jesper Haaning

Company: Novo Nordisk

Job title: Vice President, Global Research Project & Biopharm Management

Seminars:

Panel Discussion: Improving Current Standard of Care 2:30 pm

Moving towards personalised treatment options What are the roles of each therapy at what stage Is there a need for an extended factor half-life product? Defining protection and goal for treatment New product treatment paradigm How are novel therapies impacting the marketRead more

day: Day One

Clinical Development of Concizumab, a Monoclonal Antibody for Subcutaneous Prophylaxis for all Hemophilia Patients 9:30 am

Assessment and discussion of Concizumab phase II data Treatment that improve clinical outcomes and improve quality of life Future development plansRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.